Lumida
/GERN
⌘K
Geron Corp

Geron Corp

GERN
$1.35USD-1.46%-0.02 today

MARKET CAP

867.3M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$2

AI Summary

Stalk
Sell NowMedium

GERN has decisively broken key support and entered a Stage 3 distribution phase, with price now below declining EMAs and showing no sign of exhaustion despite extreme oversold readings. The active Support Failure pattern underscores supply dominance and further downside potential. Medium‐term bias remains bearish, and short‐term momentum favors selling now to capture the breakdown continuation before any relief rally into the broken EMA zone.

  • Q2 net revenue of $57.5M drove 17% YoY and 11% QoQ growth
  • Raised full-year 2026 guidance to $220–240M on continued demand
  • Low earnings yield and weak book‐to‐price metrics suggest overvaluation
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$1.4M$596,000$237,000$77.0M$183.9M
YoY %+450.6%-57.2%-60.2%+32386.9%+138.8%
P / Sales286.9x1533.4x5152.7x29.7x4.8x
EV / Sales333.4x1623.5x5473.8x32.7x6.2x
Gross Profit, Adj.$1.4M$596,000$237,000$77.0M$183.9M
YoY %+450.6%-57.2%-60.2%+32386.9%+138.8%
Margin %100.0%100.0%100.0%100.0%100.0%
EV / Gross Profit333.4x1623.5x5473.8x32.7x6.2x
EBITDA, Adj.$-113.2M$-138.3M$-193.5M$-173.2M$-51.1M
YoY %-49.0%-22.1%-40.0%+10.5%+70.5%
Margin %-8127.5%-23198.3%-81646.4%-224.9%-27.8%
EV / EBITDA-4.1x-7.0x-6.7x-14.6x-22.5x
EBIT$-114.0M$-138.6M$-193.9M$-173.7M$-68.6M
YoY %-48.2%-21.5%-40.0%+10.4%+60.5%
Margin %-8183.7%-23246.6%-81832.9%-225.6%-37.3%
EV / EBIT-4.1x-7.0x-6.7x-14.5x-16.7x
Net Income$-116.1M$-141.9M$-184.1M$-174.6M$-83.5M
YoY %-53.6%-22.2%-29.8%+5.2%+52.2%
Net Margin-8335.4%-23808.9%-77690.7%-226.7%-45.4%
EPS (GAAP)-$0.35-$0.37-$0.32-$0.27-$0.13
YoY %-25.0%-5.7%+13.5%+15.6%+51.9%